Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vireo Growth Inc.VREOF · Entity 5397 | Chief Financial Officer | November 13, 2025 | December 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vireo Growth Inc.
Report date November 13, 2025 · Filed December 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Subordinate Voting SharesSEC Table I · non-derivative | Direct | 5,507,180 |
Ending reported balance
After 2025-12-29 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2025-11-13 · Grant · Acquired 1,018,868 · Balance 3,858,868 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Row 2 · 2025-12-17 · Grant · Acquired 2,850,000 · Balance 6,708,868 F2: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 2,850,000 RSUs on December 17, 2025; 3,325,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to the reporting person remaining a Service Provider on each such vesting date). Row 3 · 2025-12-17 · Grant · Acquired 1,188,707 · Balance 7,897,575 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Row 4 · 2025-12-29 · Tax withholding · Disposed 481,554 · Balance 7,416,021 F3: Certain RSUs held by the reporting person vested on November 13, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 481,554 subordinate voting shares were withheld for tax purposes. Row 5 · 2025-12-29 · Tax withholding · Disposed 1,908,841 · Balance 5,507,180 F4: Certain RSUs held by the reporting person vested on December 17, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 1,908,841 subordinate voting shares were withheld for tax purposes. |
| Restricted stock unitsSEC Table II · derivative / convertible security | Direct | 6,650,000 |
Reported balance
After 2025-12-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-12-17 · Exercise / conversion · Disposed 2,850,000 · Balance 6,650,000 F2: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 2,850,000 RSUs on December 17, 2025; 3,325,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to the reporting person remaining a Service Provider on each such vesting date). |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately.
F2: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 2,850,000 RSUs on December 17, 2025; 3,325,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to the reporting person remaining a Service Provider on each such vesting date).
F3: Certain RSUs held by the reporting person vested on November 13, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 481,554 subordinate voting shares were withheld for tax purposes.
F4: Certain RSUs held by the reporting person vested on December 17, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 1,908,841 subordinate voting shares were withheld for tax purposes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2025 Filed Dec 30, 2025 16:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | Tax withholdingSubordinate Voting Shares | 1,908,841 | $0.67 | $1,278,923.47 |
DisclosureSEC source: 0001104659-25-125205 · tm2534512-1_4seq1.xml · nonDerivative · entry 5 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,507,180 F4 · shares: Certain RSUs held by the reporting person vested on December 17, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 1,908,841 subordinate voting shares were withheld for tax purposes. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 16:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | Tax withholdingSubordinate Voting Shares | 481,554 | $0.53 | $255,223.62 |
DisclosureSEC source: 0001104659-25-125205 · tm2534512-1_4seq1.xml · nonDerivative · entry 4 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,416,021 F3 · shares: Certain RSUs held by the reporting person vested on November 13, 2025; however, such RSUs were not settled and the subordinate voting shares underlying such RSUs were not issued to the reporting person until December 29, 2025. As of December 29, 2025, 481,554 subordinate voting shares were withheld for tax purposes. Read SEC document |
| December 17, 2025 Filed Dec 30, 2025 16:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | Exercise / conversionRestricted stock units · Derivative | 2,850,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-125205 · tm2534512-1_4seq1.xml · derivative · entry 6 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,650,000 Underlying: subordinate voting shares · 2,850,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 2,850,000 RSUs on December 17, 2025; 3,325,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to the reporting person remaining a Service Provider on each such vesting date). F2 · derivative.exercise_date: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 2,850,000 RSUs on December 17, 2025; 3,325,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to the reporting person remaining a Service Provider on each such vesting date). F2 · derivative.expiration_date: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 2,850,000 RSUs on December 17, 2025; 3,325,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to the reporting person remaining a Service Provider on each such vesting date). Read SEC document |
| December 17, 2025 Filed Dec 30, 2025 16:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 1,188,707 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-125205 · tm2534512-1_4seq1.xml · nonDerivative · entry 3 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,897,575 F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Read SEC document |
| December 17, 2025 Filed Dec 30, 2025 16:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 2,850,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-125205 · tm2534512-1_4seq1.xml · nonDerivative · entry 2 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,708,868 F2 · price: The reporting person's original Form 4 filed May 13, 2025 inadvertently included an incorrect vesting schedule. The corrected vesting schedule is as follows: 2,850,000 RSUs on December 17, 2025; 3,325,000 RSUs, at any time on or after December 17, 2026, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after December 17, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to the reporting person remaining a Service Provider on each such vesting date). Read SEC document |
| November 13, 2025 Filed Dec 30, 2025 16:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 1,018,868 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-125205 · tm2534512-1_4seq1.xml · nonDerivative · entry 1 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,858,868 F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share. Represents RSUs granted to the reporting person that vest and settle immediately. Read SEC document |
| May 09, 2025 Filed May 13, 2025 07:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantRestricted stock units · Derivative | 9,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-047560 · tm2514714-2_4seq1.xml · derivative · entry 2 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500,000 Underlying: subordinate voting shares · 9,500,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one subordinate voting share. F3 · derivative.exercise_date: The RSUs vest on the following schedule: 1/3 on the day immediately following the date on which the Registrant's 6-month trailing, annualized, adjusted EBITDA exceeds US$150,000,000 and the net leverage of the Company is below 2.2x; 1/3 on the day immediately following the day on which the adjusted EBITDA exceeds US$165,000,000 and the net leverage of the Registrant is below 2.2x; and 1/3 on the day immediately following the date on which the adjusted EBITDA exceeds US$205,000,000 and the net leverage of the Registrant is below 2.2x. F3 · derivative.expiration_date: The RSUs vest on the following schedule: 1/3 on the day immediately following the date on which the Registrant's 6-month trailing, annualized, adjusted EBITDA exceeds US$150,000,000 and the net leverage of the Company is below 2.2x; 1/3 on the day immediately following the day on which the adjusted EBITDA exceeds US$165,000,000 and the net leverage of the Registrant is below 2.2x; and 1/3 on the day immediately following the date on which the adjusted EBITDA exceeds US$205,000,000 and the net leverage of the Registrant is below 2.2x. Read SEC document |
| May 09, 2025 Filed May 13, 2025 07:01 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantRestricted stock units · Derivative | 9,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-047560 · tm2514714-2_4seq1.xml · derivative · entry 1 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,500,000 Underlying: subordinate voting shares · 9,500,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one subordinate voting share. F2 · derivative.exercise_date: The RSUs vest on the following schedule: 2,850,000 RSUs on March 6, 2026; 3,325,000 RSUs, at any time on or after March 6, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after March 6, 2028, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Macdonald remaining a Service Provider on each such vesting date). F2 · derivative.expiration_date: The RSUs vest on the following schedule: 2,850,000 RSUs on March 6, 2026; 3,325,000 RSUs, at any time on or after March 6, 2027, on the day immediately following the date on which the subordinate voting shares have reached a 30-day volume-weighted average price ("VWAP") that exceeds US$0.85; and 3,325,000 RSUs, at any time on or after March 6, 2028, on the day immediately following the date on which the subordinate voting shares have reached a 30-day VWAP that exceeds US$1.05 (subject to Mr. Macdonald remaining a Service Provider on each such vesting date). Read SEC document |
| December 17, 2024 Filed Dec 23, 2024 15:34 UTC | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 3,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-021112 · form4.xml · nonDerivative · entry 1 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200,000 F1 · shares: Represents subordinate voting shares granted to Mr. Macdonald under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, that vest on the grant date. Read SEC document |
| December 17, 2024 Filed Jan 8, 2025 13:24 UTC Amendment | Vireo Growth Inc. VREOF · Entity 5397 | Tax withholdingSubordinate Voting Shares | 360,000 | $0.25 | $90,000.00 |
DisclosureSEC source: 0001104659-25-001962 · tm252254-1_4aseq1.xml · nonDerivative · entry 2 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,840,000 Read SEC document |
| December 17, 2024 Filed Jan 8, 2025 13:24 UTC Amendment | Vireo Growth Inc. VREOF · Entity 5397 | GrantSubordinate Voting Shares | 3,200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001962 · tm252254-1_4aseq1.xml · nonDerivative · entry 1 Macdonald Tyson · CIK 0002049701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,200,000 F1 · shares: Represents subordinate voting shares granted to Mr. Macdonald under the Vireo Health International Inc. 2019 Equity Incentive Plan, as amended, that vest on the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.